-

Insights into Biologic API Contract Manufacturer Quality Benchmarking - Featuring Aji Bio-Pharma, Avid Bioservices & Batavia Bioscience Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Biologic API Contract Manufacturer Quality Benchmarking (5th Edition)" report has been added to ResearchAndMarkets.com's offering.

This report brings with it a wealth of knowledge and information created with two goals in mind, help biopharmaceutical companies make more informed CMO decisions, and help CMOs optimize operational and marketing strategies.

This report provides pharmaceutical companies and contract manufacturers a comprehensive analysis of current outsourcing trends and practices, in addition to a quantitative analysis of CMO service quality across a series of 22 performance attributes specific to outsourced drug substance manufacturing. In this Consumer Reports-style analysis, ISR presents data on 509 service encounters from 179 respondents who have been involved in outsourced biologic API projects in the past 18 months.

What You Will Learn:

Drug developers:

  • Make a more educated purchase of CMO services by understanding which manufacturers best fit your company's needs in addition to how individual CMOs have measured up to sponsor-peer expectations on similar projects
  • Uncover which CMO attributes drive outsourcing partner selection for outsourced bioprocessing as well as which CMO attributes have gained importance over the past 12 months among industry peers
  • Gain insight into CMO customer loyalty, an index based on customer satisfaction, willingness to recommend, and likelihood to use again, along with verbatim responses from customers regarding their experience

Contract Manufacturers:

  • Understand your company's competitive positioning as well as delivery strengths and weaknesses and use this information to develop targeted messaging on true areas of strength
  • Compare your company's performance against its competitors across 22 performance metrics specific to outsourced bioprocessing
  • Gain insight into drug developers' outsourcing preferences and practices when it comes to CMO selection and CMO preference for outsourced biologic API manufacturing

Major Topics:

  • Outsourcing Philosophies and Practices
  • CMO Selection Drivers
  • CMO Perceptions and Interactions
  • CMO Performance and Loyalty
  • Biologic API CMO Competitive Landscape
  • Company Service Quality Profiles
  • Study Data
  • Demographics

Key Topics Covered:

1. Outsourcing Philosophies and Practices

  • Primary Section Takeaways
  • Outsourced Manufacturing Activities
  • Outsourcing Drivers
  • Outsourcing Drivers by Company Size
  • Outsourcing Models
  • Preferred Providers
  • Number of Preferred Providers

2. CMO Selection Drivers

  • Primary Section Takeaways
  • Most Important CMO Attributes
  • CMO Attributes Gaining Importance

3. CMO Perceptions and Interactions

  • Primary Section Takeaways
  • CMO Familiarity
  • CMO Leaders - Unprompted
  • CMO Leaders - Prompted
  • Received Proposals
  • CMO Use
  • CMO Preference
  • CMO Preference Among Users
  • CMO Cost Perceptions
  • Summary Table

4. CMO Performance and Loyalty

  • Primary Section Takeaways
  • A Note on Performance Calculations
  • Performance Across Providers
  • Figure 1 - CMO Performance:
  • Delivery Factors
  • Figure 2 - CMO Performance:
  • Organization Factors
  • Figure 3 - CMO Performance:
  • Capabilities
  • Figure 4 - CMO Performance:
  • Staff Characteristics
  • Figure 5 - CMO Performance:
  • Service Capabilities
  • CMO Loyalty
  • CMO Loyalty: 3-Year Rolling Average

5. Biologic API CMO Competitive Landscape

  • Company Service Quality Profiles

6. Study Data

  • Outsourced Manufacturing Activities
  • Outsourcing Drivers
  • Outsourcing Models
  • Use of Preferred Providers
  • Number of Preferred Providers
  • Large Molecule Product Offering
  • Large vs. Small Molecule Outsourcing
  • CMO Selection Attributes
  • CMO Selection Attributes Gaining Importance
  • CMO Leaders, Unprompted
  • Other Responses (1%)
  • CMO Familiarity
  • CMO Leaders, Prompted
  • Received Proposals
  • CMO Use
  • CMO Preference
  • CMO Cost Perceptions
  • CMO Drill-downs
  • CMO Satisfaction Rating Explanations

7. Demographics

  • Company Type
  • Headquarters Location
  • Office Location
  • Job Title
  • Decision-making Responsibility
  • Biologic Drug Substance Outsourcing
  • Contract Manufacturing Responsibilities
  • Involvement in Outsourced Manufacturing
  • Contract Manufacturing Involvement
  • Years of Industry Experience

Companies Mentioned

  • AbbVie
  • Abzena
  • AGC Biologics
  • Aji Bio-Pharma
  • Avid Bioservices
  • Batavia Bioscience
  • Boehringer Ingelheim
  • Brammer Bio
  • Catalent
  • Celltrion
  • Celonic
  • CEPiA Sanofi
  • Cobra Biologics
  • Cognate Bioscience
  • Cytovance
  • Emergent Biosolutions
  • Fujifilm Diosynth Biotechnologies
  • Genscript
  • GSK Contract Manufacturing
  • IDT Biologika
  • Kaneka Eurogenic
  • KBI Biopharma
  • Kemwell Biopharma
  • Lonza
  • Luina Bio
  • Millipore Sigma
  • Novasep
  • Paragon Gene Therapy
  • Patheon
  • Polpharma
  • Rentschler
  • Richter-Helm
  • Samsung BioLogics
  • Sandoz
  • Syngene International
  • Therapure Biopharma
  • VxP Biologics
  • Wacker Biotech
  • Wuxi Biologics

For more information about this report visit https://www.researchandmarkets.com/r/n8y3vi

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

1 Day Clinical Trial Agreements Training Course: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets (Mar 18, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Clinical Trial Agreements: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets Training Course (Mar 18, 2026)" training has been added to ResearchAndMarkets.com's offering. The life sciences sector is heavily regulated and CTAs are some of the most important agreements for companies operating in this sector. Having appropriate CTAs in place is therefore essential for managing relationships between the diffe...

Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training Course (Mar 2nd - Mar 3rd, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training Course (Mar 2nd - Mar 3rd, 2026)" training has been added to ResearchAndMarkets.com's offering. Understand the regulatory frameworks governing drug/device and device/drug combinations in the European Union and the USA. The demarcation between medicinal products and devices is becoming ever more important and, with the conve...

Wedding Rings Market Trends, Shares and Growth Prospects 2025-2030 - Cultural and Social Trends Around Minimalism and Modern Design Drive Adoption of Non-Traditional Styles - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Wedding Rings - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Wedding Rings was valued at US$56.7 Billion in 2024 and is projected to reach US$80.7 Billion by 2030, growing at a CAGR of 6.1% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The wedding ring market is expanding due to a combin...
Back to Newsroom